Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies: Which Stock Should You Track
- September 25, 2026
- Posted by: Harsh Piplani
- Category: Market
Zydus Lifesciences PE 25.63, mkt cap Rs 1,17,705 crore. IOL Chemicals and Pharmaceuticals PE 35.57, mkt cap Rs 5,982 crore. Indoco Remedies PE NA, mkt cap Rs 2,312 crore.
Quick Answer
Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies is a side-by-side comparison of three companies from the Pharma Formulations (Fifth Fresh Set) space. On this comparison, Zydus Lifesciences carries a market capitalisation of about Rs 1,17,705 crore against Rs 5,982 crore for IOL Chemicals and Pharmaceuticals and Rs 2,312 crore for Indoco Remedies, with return on equity of 18.59%, 7.65% and -10.13% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.
Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies starts with the core numbers most investors compare within the Pharma Formulations (Fifth Fresh Set) segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Pharma Formulations (Fifth Fresh Set) bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies: Company Overview
Zydus Lifesciences is a listed Indian company in the Pharma Formulations (Fifth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
IOL Chemicals and Pharmaceuticals is a listed Indian company in the Pharma Formulations (Fifth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Indoco Remedies is a listed Indian company in the Pharma Formulations (Fifth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies: Valuation and Profitability Snapshot
| Metric | Zydus Lifesciences | IOL Chemicals and Pharmaceuticals | Indoco Remedies |
|---|---|---|---|
| Market Cap (approx.) | Rs 1,17,705 crore | Rs 5,982 crore | Rs 2,312 crore |
| PE Ratio (TTM) | 25.63 | 35.57 | NA |
| PB Ratio | 4.34 | 3.33 | 2.46 |
| Return on Equity (ROE) | 18.59% | 7.65% | -10.13% |
| EPS (TTM, Rs) | 46.04 | 5.73 | 0.34 |
| Dividend Yield | 0.09% | 0.49% | 0.08% |
| Debt to Equity | 0.46 | 0.08 | 1.16 |
| Book Value per Share (Rs) | 271.78 | 61.27 | 101.76 |
Check the Univest Screener for Live Data
On valuation, Zydus Lifesciences trades at a PE of 25.63 and a PB of 4.34, IOL Chemicals and Pharmaceuticals at a PE of 35.57 and a PB of 3.33, while Indoco Remedies trades at a PE of NA and a PB of 2.46. On return on equity, the three post 18.59%, 7.65% and -10.13% respectively, and on dividend yield they stand at 0.09%, 0.49% and 0.08%.
Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| Zydus Lifesciences | Rs 8,123.10 crore | Rs 952.40 crore | +20.7% | +5.2% |
| IOL Chemicals and Pharmaceuticals | Rs 764.44 crore | Rs 64.40 crore | +36.7% | +23.0% |
| Indoco Remedies | Rs 469.68 crore | Rs 65.44 crore | +6.4% | -1.2% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY28, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three pharma formulations (fifth fresh set) names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies highlights how differently three companies in the same pharma formulations (fifth fresh set) segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies
What is the market cap difference between Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies?
Ans. As of September 2026, Zydus Lifesciences has a market cap of approximately Rs 1,17,705 crore, IOL Chemicals and Pharmaceuticals is at approximately Rs 5,982 crore, and Indoco Remedies is at approximately Rs 2,312 crore.
Which of the three has the highest PE ratio?
Ans. Among Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies, the PE ratios stand at 25.63, 35.57 and NA respectively as of September 2026.
Which of the three has the highest ROE?
Ans. Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies post ROE of 18.59%, 7.65% and -10.13% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies carry dividend yields of 0.09%, 0.49% and 0.08% respectively.
What is the debt to equity ratio for Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies?
Ans. Zydus Lifesciences carries a debt to equity of 0.46, IOL Chemicals and Pharmaceuticals of 0.08, and Indoco Remedies of 1.16.
Which of the three trades at the highest price to book value?
Ans. Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies trade at price to book ratios of 4.34, 3.33 and 2.46 respectively.
Is one of Zydus Lifesciences, IOL Chemicals and Pharmaceuticals or Indoco Remedies better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.
